Is the G2019S LRRK2 mutation common in all southern European populations?

Journal of Clinical Neuroscience

Volumn 15, Issue 9, 2008, Pages 1027-1030

  Papapetropoulos, Spiridon ^a   Adi, Nikhil ^b   Shehadeh, Lina ^a,c   Bishopric, Nanette ^a   Singer, Carlos ^a   Argyriou, Andreas A ^b   Chroni, Elizabeth ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^c FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Frequency; Geographic distribution; LRRK2; Mutations; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; LEUCINE RICH REPEAT KINASE 2;

ADULT; AGED; ARTICLE; ASIAN; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DNA POLYMORPHISM; EUROPE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GEOGRAPHIC DISTRIBUTION; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POPULATION GENETIC PARAMETERS; PRIORITY JOURNAL;

AGED; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; FOUNDER EFFECT; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GREECE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PENETRANCE; POLYMORPHISM, GENETIC; PREVALENCE; PROTEIN-SERINE-THREONINE KINASES;

EID: 48449089238     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.08.013     Document Type: Article

References (42)

1. Cordato D.J., and Chan D.K. Genetics and Parkinson's disease. J Clin Neurosci 11 (2004) 119-123
2. Papapetropoulos S., Singer C., Ross O.A., et al. Clinical heterogeneity of the LRRK2 G2019S mutation. Arch Neurol 63 (2006) 1242-1246
3. Paisan-Ruiz C., Jain S., Evans E.W., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
4. Zimprich A., Biskup S., Leitner P., et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44 (2004) 601-607
5. Di Fonzo A., Rohe C.F., Ferreira J., et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365 (2005) 412-415
6. Hernandez D.G., Paisan-Ruiz C., McInerney-Leo A., et al. Clinical and positron emission tomography of Parkinson's disease caused by LRRK2. Ann Neurol 57 (2005) 453-456
7. Kachergus J., Mata I.F., Hulihan M., et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 76 (2005) 672-680
8. Nichols W.C., Pankratz N., Hernandez D., et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365 (2005) 410-412
9. Rajput A., Dickson D.W., Robinson C.A., et al. Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 67 (2006) 1506-1508
10. Lu C.S., Simons E.J., Wu-Chou Y.H., et al. The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease. Parkinsonism Relat Disord 11 (2005) 521-522
11. Goldwurm S., Zini M., Di Fonzo A., et al. LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample. Parkinsonism Relat Disord 12 (2006) 410-419
12. Infante J., Rodriguez E., Combarros O., et al. LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease. Neurosci Lett 395 (2006) 224-226
13. Bras J.M., Guerreiro R.J., Ribeiro M.H., et al. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Mov Disord 20 (2005) 1653-1655
14. Ozelius L.J., Senthil G., Saunders-Pullman R., et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 354 (2006) 424-425
15. Lesage S., Durr A., Tazir M., et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 354 (2006) 422-423
16. Goldwurm S., Di Fonzo A., Simons E.J., et al. The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor. J Med Genet 42 (2005) e65
17. Lesage S., Leutenegger A.L., Ibanez P., et al. LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century. Am J Hum Genet 77 (2005) 330-332
18. Cossu G., van Doeselaar M., Deriu M., et al. LRRK2 mutations and Parkinson's disease in Sardinia-A Mediterranean genetic isolate. Parkinsonism Relat Disord 13 (2007) 17-21
19. Spanaki C., Latsoudis H., and Plaitakis A. LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP. Neurology 67 (2006) 1518-1519
20. Xiromerisiou G., Hadjigeorgiou G.M., Gourbali V., et al. Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants. Eur J Neurol 14 (2007) 7-11
21. Papapetropoulos S., Ellul J., Paschalis C., et al. Clinical characteristics of the α-synuclein mutation (G209A)-associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece. Eur J Neurol 10 (2003) 281-286
22. Papapetropoulos S., Paschalis C., Athanassiadou A., et al. Clinical phenotype in patients with α-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease. J Neurol Neurosurg Psychiatry 70 (2001) 662-665
23. Tan E.K., Zhao Y., Skipper L., et al. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum Genet 120 (2006) 857-863
24. Hughes A.J., Daniel S.E., Kilford L., et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
25. Zabetian C.P., Hutter C.M., Yearout D., et al. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: Evidence of two distinct founding events beginning two millennia ago. Am J Hum Genet 79 (2006) 752-758
26. Punia S., Behari M., Govindappa S.T., et al. Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients. Neurosci Lett 409 (2006) 83-88
27. Lesage S., Ibanez P., Lohmann E., et al. G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann Neurol 58 (2005) 784-787
28. Di Fonzo A., Tassorelli C., De Mari M., et al. Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 14 (2006) 322-331
29. Aasly J.O., Toft M., Fernandez-Mata I., et al. Clinical features of LRRK2-associated Parkinson's disease in central Norway. Ann Neurol 57 (2005) 762-765
30. Ross O.A., Toft M., Whittle A.J., et al. Lrrk2 and Lewy body disease. Ann Neurol 59 (2006) 388-393
31. Gilks W.P., Abou-Sleiman P.M., Gandhi S., et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365 (2005) 415-416
32. Paisan-Ruiz C., Lang A.E., Kawarai T., et al. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology 65 (2005) 696-700
33. Kay D.M., Zabetian C.P., Factor S.A., et al. Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics. Mov Disord 21 (2006) 519-523
34. Deng H., Le W., Guo Y., et al. Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation. Ann Neurol 57 (2005) 933-934
35. Hernandez D., Paisan Ruiz C., Crawley A., et al. The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases. Neurosci Lett 389 (2005) 137-139
36. Zabetian C.P., Samii A., Mosley A.D., et al. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 65 (2005) 741-744
37. Farrer M., Stone J., Mata I.F., et al. LRRK2 mutations in Parkinson disease. Neurology 65 (2005) 738-740
38. *. Brain 128 (2005) 3000-3011
39. Tan E.K., Shen H., Tan L.C., et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neurosci Lett 384 (2005) 327-329
40. Bialecka M., Hui S., Klodowska-Duda G., et al. Analysis of LRRK2 G 2019 S and I 2020 T mutations in Parkinson's disease. Neurosci Lett 390 (2005) 1-3
41. Squillaro T., Cambi F., Ciacci G., et al. Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease. J Hum Genet 52 (2007) 201-204
42. Ishihara L., Gibson R.A., Warren L., et al. Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Mov Disord 22 (2007) 55-61